Literature DB >> 9890104

Measures of disease activity and damage in SLE.

M B Urowitz1, D D Gladman.   

Abstract

Criteria for the classification of systemic lupus erythematosus (SLE) are not sufficient to describe the degree of disease activity. Several instruments to assess disease activity have been developed. This chapter reviews the derivation, validation, and clinical application of current disease activity measures in SLE, as well as comparison among them. As patients with lupus survive longer, the sequelae of the disease activity and its therapy are becoming more common. The derivation and validation of the single, generally accepted SLICC/ACR damage index is also discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9890104     DOI: 10.1016/s0950-3579(98)80027-7

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  12 in total

1.  Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus.

Authors:  K Migita; T Miyashita; Y Maeda; H Kimura; M Nakamura; H Yatsuhashi; H Ishibashi; K Eguchi
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

2.  Correlation of Buccal Micronucleus with Disease Activity Score Using Buccal Micronucleus Cytome Analysis (BMCA) in Systemic Lupus Erythematosus.

Authors:  Khalil Assiri; Mohammad Shahul Hameed; Ali Azhar Dawasaz; Eman Alamoudi; Alhussain Mohammad Asiri; Vij Hitesh; Muhammed Ajmal
Journal:  Indian J Dermatol       Date:  2020 Jul-Aug       Impact factor: 1.494

Review 3.  Central pain mechanisms in the rheumatic diseases: future directions.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2013-02

4.  Effect of lower dose intravenous cyclophosphamide on remission induction in Korean patients with lupus nephritis.

Authors:  Sang-Seokg Seong; Chan-Bum Choi; Hye-Ryeon Yun; Yoon-Jeong Kim; Yoon-Kyoung Sung; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2007-10-09       Impact factor: 2.631

5.  Prevalence of the American College of Rheumatology classification criteria in a group of 162 systemic lupus erythematosus patients from Croatia.

Authors:  Mislav Cerovec; Branimir Anić; Ivan Padjen; Nada Cikes
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

6.  Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.

Authors:  Vinod Umare; Vandana Pradhan; Milind Nadkar; Anjali Rajadhyaksha; Manisha Patwardhan; Kanjaksha K Ghosh; Anita H Nadkarni
Journal:  Mediators Inflamm       Date:  2014-12-07       Impact factor: 4.711

7.  New classification criteria for systemic lupus erythematosus correlate with disease activity.

Authors:  Felina Anić; Marta Zuvić-Butorac; Davor Stimac; Srđan Novak
Journal:  Croat Med J       Date:  2014-10       Impact factor: 1.351

8.  Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?

Authors:  V Umare; A Nadkarni; M Nadkar; A Rajadhyksha; P Khadilkar; K Ghosh; V D Pradhan
Journal:  J Postgrad Med       Date:  2017 Apr-Jun       Impact factor: 1.476

9.  IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).

Authors:  Vilija Oke; Susanna Brauner; Anders Larsson; Johanna Gustafsson; Agneta Zickert; Iva Gunnarsson; Elisabet Svenungsson
Journal:  Arthritis Res Ther       Date:  2017-06-15       Impact factor: 5.156

10.  Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review.

Authors:  Sai Yan Yuen; Adriana Krizova; Janine M Ouimet; Janet E Pope
Journal:  Open Rheumatol J       Date:  2008-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.